ANDRAŠINA, Tomáš, Tomáš ROHAN, Hiroko MARTIN, Jiří PÁNEK, Petra KOVALČÍKOVÁ, Tomáš GROLICH, Lenka OSTŘÍŽKOVÁ and Vlastimil VÁLEK. Percutaneous Endoluminal Forceps Biopsy in Cholangiocellular Carcinoma - A Perspective Approach to Timeliness of Diagnostic Confirmation Using Two Scenarios. Japanese Journal of Gastroenterology and Hepatology. 2019, vol. 3, Jun 2019, p. 1-8. ISSN 2435-1210.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Percutaneous Endoluminal Forceps Biopsy in Cholangiocellular Carcinoma - A Perspective Approach to Timeliness of Diagnostic Confirmation Using Two Scenarios
Authors ANDRAŠINA, Tomáš (703 Slovakia, belonging to the institution), Tomáš ROHAN (203 Czech Republic, guarantor, belonging to the institution), Hiroko MARTIN (840 United States of America, belonging to the institution), Jiří PÁNEK (203 Czech Republic, belonging to the institution), Petra KOVALČÍKOVÁ (203 Czech Republic, belonging to the institution), Tomáš GROLICH (203 Czech Republic), Lenka OSTŘÍŽKOVÁ (203 Czech Republic) and Vlastimil VÁLEK (203 Czech Republic, belonging to the institution).
Edition Japanese Journal of Gastroenterology and Hepatology, 2019, 2435-1210.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30224 Radiology, nuclear medicine and medical imaging
Country of publisher Japan
Confidentiality degree is not subject to a state or trade secret
WWW URL
RIV identification code RIV/00216224:14110/19:00108515
Organization unit Faculty of Medicine
Keywords in English biliary intervention; endoluminal forceps biopsy; cholangiocellular carcinoma
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 27/2/2020 13:07.
Abstract
1.1. Aim: To assess the benefits of performing endoluminal forceps biopsy during initial drainage compared to postponed biopsy using two patient management scenarios. 1.2. Methods: Since 2006, 101 consecutive patients with malignant biliary stenosis due to cholangiocellular carcinoma have been followed up. All patients underwent a percutaneous biliary drainage (PBD) procedure and endoluminal forceps biopsy to obtain histological verification of stenosis. The cumulative success rate, complication rate, time needed to obtain diagnosis, and procedural costs were studied in two scenarios. In the first scenario, 59 patients underwent percutaneous drainage first and after 1–40 (median 7) days, had a postponed biopsy using multi-use 7.5F biopsy forceps. In the second scenario, 42 patients underwent percutaneous drainage and successive biopsy in a single, combined procedure using 5.2F disposable biopsy forceps. 1.3. Results: Interventions with a single-procedure PBD biopsy were not associated with a higher rate of complications. The cumulative success rates of endoluminal biopsy in both scenarios were 81% and 76%, respectively. The average time needed to obtain a conclusive biopsy specimen from the time of initial drainage were 47 days and 10 days (p = 0.002). Patients undergoing endoluminal biopsy with the 5.2F forceps benefited from 2,1 fewer percutaneous interventions on average (p< 0.001) and procedural expenses per patient were on average 1.84 times lower (p< 0.001). 1.4. Conclusion: Percutaneous forceps biopsy is a safe procedure even when performed during initial drainage. Its success rate is comparable to that of the postponed biopsy procedure, meanwhile malignancy is determined significantly sooner and healthcare expenses are significantly lower.
Links
MUNI/A/1574/2018, interní kód MUName: Onkologické radiologické intervence a jejich přínos v rámci komplexní onkologické léčby, srovnání s celorepublikovými výsledky onkologické léčby vybraných diagnóz II
Investor: Masaryk University, Category A
NV15-32484A, research and development projectName: Využití nových biotechnologií v prevenci a léčbě stenóz žlučových cest
ROZV/24/LF/2018, interní kód MUName: LF - Příspěvek na IP 2108
Investor: Ministry of Education, Youth and Sports of the CR, Internal development projects
PrintDisplayed: 6/10/2024 14:46